Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy and Safety of TQB2102 for Injection Versus Investigator-Selected Chemotherapy in HER2 Low-Expressing Recurrent/Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of TQB2102 for injection versus investigator-selected chemotherapy in HER2-low expressing recurrent/metastati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• TQB2102

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Breast Cancer | Phase 3 | Status: NOT_YET_RECRUITING